You are here

Purification and Culture of Dendritic Langerhans Cells

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 21921
Amount: $35,438.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Solicitation Year: N/A
Award Year: 1993
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
5301 Patrick Henry Drive
Santa Clara, CA 95054
United States
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 David A. Okrongly
 (408) 492-9200
Business Contact
Phone: () -
Research Institution

Methods for obtaining highly purified Langerhans Cells (LC) directly from epidermis or by directed differentiation of CD34+ progenitor cells are proposed. Development and commercialization of products for LC purification will aid basic research on the role of LC in skin diseases such as psoriasis, Kaposi's sarcoma and atopic dermatitis. The therapeutic goal of the work is to develop a method of growing LC from bone marrow and use the LC as an antigen presenting cell line for cytotoxic CD8+ T cells. We propose applying this system in an immunotherapeutic approach to AIDS; this system will be based on the use of HIV-associated antigens in the LC culture system. The system may provide a generally applicable method for generation of antigen specific cytotoxic T cells.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government